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Objective: Statins stimulate bone formation by inducing the expression of bone morphogenetic
proteins (BMP-2). The aim of our study was to investigate the effects of orally administered simvastatin on spinal fusion in rats.
Methods: Twenty rats were randomized into a spinal fusion group (SF) (n=10) or a spinal fusion
and oral simvastatin administered group (SFS) (n=10). A spinal fusion was performed between
L4-L6 representing two levels. Simvastatin (120 mg/kg/day) was administered orally in the SFS
group. The rats were killed at the end of the 12 week study period.
Results: Manual palpation revealed two moderate fusions in the SF group. The SFS group did
not reveal any signs of pseudoarthrosis. An average three-point bending force causing failure of
fusion revealed results of 148.80±39.403 Newtons and 123.80±28.479 Newtons in SFS and SF
groups, respectively (p>0.05). Histological examination revealed better fusion grades in the SFS
group (mean: 9.30±0.949) than in the SF group (mean: 6.80±2.044) (p=0.003). Radiographic
examination revealed Grade C fusion in two levels and Grade A fusion in 18 levels in the SF
group. In the SFS group, Grade C fusion was detected in one level and Grade A fusions in 19.
Conclusion: Our results suggest that simvastatin can promote spinal fusion and can be used as
an adjunct to spinal fusion procedures in an elderly population with high cholesterol levels.
Key words: BMP; pseudoarthrosis; simvastatin; spinal fusion; statin.

Specific competitive inhibitors of 3-hydroxy-3methlyglutaryl coenzyme A reductase (HMG-CoA
reductase) –such as fluvastatin, lovastatin, simvastatin, pravastatin, and atorvastatin– are widely used
agents for lipid reduction, and lessen the risk of arteriosclerosis with minimal side effects.[1-3] It has been
reported that statins, especially lovastatin and simvastatin, stimulate bone healing and formation by
inducing the expression of bone morphogenetic pro-

teins (BMP-2).[4] Bone morphogenetic proteins are
important regulators of the healing of bone fractures.[5] Posterior spinal fusion, which mimics the
healing process of the bone, is commonly used for
spinal operations, such as spondylolisthesis, scoliosis, kyphosis, degenerative spinal disorders and
tumors.[6,7] In the present study, our aim was to investigate the effects of orally administered simvastatin
on spinal fusion in rats.
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Materials and methods
All procedures were conducted in accordance with
the National Institute of Health’s Guide for the Care
and Use of Animals and were approved by the local
ethical committee. Twenty male Sprague Dawley
rats (mean age: 6 months; range: 5-6 months), each
weighing 300 grams, were used. The rats were
housed in polycarbonate cages and fed with standard
food and water. The rats were randomized into two
groups; a spinal fusion group (SF; n=10) or a spinal
fusion and oral simvastatin administered group
(SFS; n=10). Both groups were fed chocolate for 10
days before the operation. In the SFS group, simvastatin was crushed and mixed with the chocolate to be
administered orally at a dose of 120 mg/kg/day
(Zocor; Merck, NJ, USA) for seven days preoperatively and continued for 12 weeks postoperatively.
An equal amount of chocolate was given to the rats
in the SF group. The rats were operated on using the
technique described by Dimar.[7] Animals were anesthetized with a 0.45 cc intraperitoneal injection of a
solution with a ratio of 60 mg/kg ketamine and 6
mg/kg xylazine. Intramuscular Penicillin G (100,000
U) was used as an infection prophylaxis before the
operation. Next, the animals were affixed to a small
operating table and shaved and the operation side
was sterilized with a 10% povidone iodine solution.
To harvest a bone graft from the tail, the tail was
amputated and all soft tissue was removed from the
bone using forceps, rongeurs and scalpels. Five vertebrae were separated from the intervertebral discs
and all periosteum was removed (Fig. 1). The bone
was morselized with rongeurs and weighed to create
a homogenous distribution of the grafts between the
groups. The average bone graft was 0.30 g (range:
0.25-0.32 g). A dorsal longitudinal incision was
made from L3 through the sacral midline for the posterior spinal fusion procedure. The subcutaneous tissue was sharply dissected and the paravertebral muscles were detached and retracted laterally to the facet
joints with automatic retractors. After the meticulous
removal of all the posterior spinal soft tissues, decortication of the dorsal surfaces of transverse processes and facet joints was performed with an electrical
high-speed burr (Core Ref 5400-50; Stryker, MI,
USA). A hole was created in the spinous process of

L4, L5 and L6 (representing two level fusion), and a
stainless cerclage wire was passed in a figure-ofeight fashion to enhance stabilization. After stabilization, the autogenous bone graft harvested from
the tails was placed along the posterior lamina and
transverse processes (Fig. 2). The paraspinal muscles were closed with a running suture and the incision was closed with metal clips.
All animals survived for 12 weeks and at the end
of the 12 week period they were killed using an
intra-abdominal injection of pentobarbital (100
mg/kg body weight). All soft tissue and muscles
were dissected from the spinal segment L2 through
the sacrum. The lumbar vertebrae and the sacrum
were then enblock resected. All cerclage wires were
removed and the fusion sites were assessed by three
examiners using a manual palpation method for the
signs of pseudoarthrosis[7] (Table 1). Micro-motions
in either plane (coronal and sagittal) were assessed
for each level (L4-L5 and L5-L6). Radiographies of

Fig. 1.

All soft tissues of the tail were cleaned. [Color figure can
be viewed in the online issue, which is available at
www.aott.org.tr]

Fig. 2.

Morselized bone graft taken from the tail placed over the
decorticated posterior lamina and facet joints. [Color figure can be viewed in the online issue, which is available at
www.aott.org.tr]
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all animals were taken and an assessment of fusion
mass was performed according to Lenke et al.[8]
(Table 1; Figs. 3 and 4). A biomechanical threepoint bending test was performed using a mechanical testing device (Hounsfield H50KM; Hounsfield
Test Equipment Ltd., Surrey, England). The specimens were placed on the machine with the dorsal
sides facing towards the tip of the force applier.
Force was applied to the middle of the fused segment at a constant rate of 10 mm/minute until failure
occurred. The force at the time of the failure was
recorded in Newton units.
Histological examination was made in both
groups. After removal of their soft tissue, the spinal
segments from L2 to the sacrum were fixed in a
solution of 10% formalin, decalcified and stained
with a standard hematoxylin eosin stain. Next,
examination was made under standard light
microscopy. Histological examination was made as
described in the study by Huddlestone et al.[9] (Table
1), on four fields per specimen (each specimen had
two levels, and each level two fields; right and left).
The scores of the four fields were averaged.

Table 1. Assessment of fusion by manual palpation, histological
examination and radiography.
Grade of fusion

Manual palpation (Dimar et al.[7])

Solid

No micro-motion in anteroposterior and lateral planes

Moderate

Micro-motion in one plane

Pseudoarthrosis

Unrestricted motion in either plane

Grade of fusion

Histological examination (Huddlestone et al.[9])

Grade 1

Fibrous tissue

Grade 2

Predominantly fibrous tissue with some cartilage

Grade 3

Equal amount of fibrous tissue with some cartilage

Grade 4

All cartilage

Grade 5

Predominantly cartilage with some woven bone

Grade 6

Equal amount of cartilage and woven bone

Grade 7

Predominantly woven bone with some cartilage

Grade 8

Entirely woven bone

Grade 9

Woven bone with some mature bone

Grade 10

Lamellar (mature) bone

Grade of fusion

Radiographic evaluation (Lenke et al.[8])

A

Definitely big trabeculated bilateral fusion mass

B

Possibly solid unilateral large fusion mass with
contralateral small fusion mass

C

Probably not solid, thin fusion masses bilaterally

D

Definitely not solid, graft resorption bilaterally

Statistical analysis

Results

A Kolmogorov-Smirnov test was used to determine
the distribution of the two groups. Two independent
t-tests were used to compare the biomechanical threepoint bending forces and histopathological scores of
group SF and group SFS. Significance level was set
at p<0.05 and calculations were performed using
SPSS software (SPSS Inc., IL, USA).

Manuel palpation revealed two moderate fusions in 20
levels (90%) in the SF group, whereas the treatment
group revealed no signs of pseudoarthrosis in 20 levels. An average three-point bending force causing failure of fusion revealed 148.80±39.403 Newtons and
123.80±28.479 Newtons in the SFS and SF groups,
respectively (p>0.05) (Table 2). Histological exami-

Fig. 3.

Radiography of the SFS group (circle showing Grade C fusion).

Fig. 4.

Radiography of the SF group (circles showing Grade C fusions).
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nation revealed better fusion grades in the SFS group,
with a mean of 9.30±0.949 than with the SF group,
with a mean of 6.80±2.044 (p=0.003) (Table 2; Figs.
5 and 6). Radiographic examination revealed Grade C
fusion in two levels and Grade A fusion in 18 levels in
the SF group. We detected Grade C fusion in one level
and Grade A fusion in 19 levels in the SFS group.
(Figs. 3 and 4).
Discussion
Posterior spinal fusion is commonly used for spinal
operations for spondylolisthesis, scoliosis, kyphosis,
degenerative spinal disorders and tumors.[6] To prevent pseudoarthrosis, new substitutes have been
used in clinical and experimental studies, such as
heterologous demineralized bone matrix, bone morphogenetic protein-7, and osteogenic protein-1.[10-13]
BMPs are important regulators of the bone in the
healing of fractures.[5] It has been reported that
statins –especially lovastatin and simvastatin– stimulate bone formation by inducing the expression of
BMP-2 and that orally administered drugs increase
cancellous bone volume.[4] Furthermore, angiogenesis is essential for bone formation.[5] Hydrophobic
statins stimulate vascular endothelial growth factor
expression in osteoblasts, which in turn promote differentiation.[14] Another effect of simvastatin on bone
formation is the inhibition of inflammation.[15]
Statins inhibit the HMG-CoA reductase enzyme
which is key in the formation of cholesterol and
other pathways, including the formation of farnesyl-

Fig. 5.

Fusion area consisting of predominantly cartilage tissue
(H-E x30). [Color figure can be viewed in the online issue,
which is available at www.aott.org.tr]

Table 2. Biomechanical and histological test results of the two
groups.
Groups

Biomechanics
mean±SD
(Newton)

Histology
mean±SD

SF group

123.80±28.479

6.80±2.04

SFS group

148.80±39.403

9.30±0.94

0.121

0.003

p

pyrophosphate (which is necessary for activation of
osteoclasts).[16] Beneficial effects of HMG-CoA
reductase inhibitors on cardiac events are mainly due
to their hypocholesterolemic effects.[17,18] Minimal
side effects of statins have been reported.[3]
Another statin, called cerivastatin, given at a high
dose (1.0 mg/kg/day) induced bone union of allograft to host bone in a rat model in one study. This
effect was attributed to more bone growth due to the
increase of BMP-2 and vascular endothelial growth
factor.[19] Rats are good candidates for spinal fusion
models.[10,20] We used a drug delivery model developed by Huang-Brown and Guhad[21] which is reported to be an effective, consistent, reliable method of
oral drug delivery to a large group of rats for a long
period of time. The meta-analysis study by Douglas
et al. suggests that statins cause significant reduction
in hip and non-spine fractures.[22]
The effect of the systemic and local administration of simvastatin on bone healing has been investi-

Fig. 6.

Mature lamellar bone and bone marrow in the healing
areas (H-E x20). [Color figure can be viewed in the online
issue, which is available at www.aott.org.tr]
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gated in several studies.[19,23-30] Wong and Rabie created 15 defects in the parietal bone of rabbits; five of
them were grafted with simvastatin collagen grafts,
five were grafted with collagen alone, and the last
group were left empty.[24] The simvastatin collagen
graft group revealed 308% more new bone formation than collagen grafts. Wong and Rabie concluded that statin collagen grafts can be used with other
bone grafting materials (such as autogenous bone
grafts) to exert their osteoinductive effects on larger
defects.[24] Mundy et al. suggested that a subcutaneous injection of simvastatin causes a 50% increase
in new bone formation in rat calvaria at 21 days; this
observation is comparable to that seen with fibroblast growth factor.[25] Wong and Rabie found that a
statin graft applied to the defect in a skull of a rabbit
induced bone formation by day five; by the 14th day,
an abundance of bone formation was detected.[26]
Stein et al. reported that locally applied simvastatin
in methylcellulose gel leads to a 45% increase in
bone area in the mandible.[29] In a study by Ma et al.,
the effect of oral simvastatin on bone formation and
ceramic resorption in a peri-implant defect model
was investigated and reported to be ineffective in
repairing defects; this was because the drug was
severely eliminated by the liver which led to poor
bioavailability.[30] In another study by Skoglund et al.
40 mice were given 120 mg/kg simvastatin orally
per day; this resulted in a 53% bigger transverse
area, a 150% increase in energy uptake at 14 days in
a femur fracture model. It was also observed that a
63% greater force was required to break the bone.[23]
This is a very high dose for animals but it is necessary for the bioavailability of the drug in the bone.
However, such high doses cannot be used in clinical
practice.
Patil et al. investigated the effect of orally administered simvastatin (20 mg/day) on fracture healing
of the distal radius in humans in a prospective, double-blind, randomized controlled trial.[28] They randomized 62 patients into two placebo and drug
groups. Thirty-one patients in the drug group did not
show significant differences with respect to fracture
healing at the end of 12 weeks. They attributed this
result to a high clearance of simvastatin in the liver
leading to inadequate levels of the drug at the bone
tissue level. Thus, in the present study, we used high
doses of simvastatin to overcome the clearance of
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the drug in the liver as did Skoglund et al. in their
study. Yee et al. reported the results of orally administered simvastatin on a spinal posterolateral fusion
model in rabbits and stated that it has no beneficial
effect on spinal fusion.[31] However, the drug dose
used in the study (6.5 mg/kg/day) was very low, and
the drug did not show a beneficial effect on the spine
due to its clearance in the liver. Because of this
observation, we used very high doses (120
mg/kg/day) to overcome this problem.
Although an average three-point bending force
causing failure of fusion was measured at 148.80
±39.403 Newtons in the SFS group and 123.80
±28.479 Newtons in the SF group, the difference
was not statistically significant in the present study
(p>0.05). However, with manual examination our
research revealed moderate fusion in two levels in
the SF group, while there was no pseudoarthrosis in
the SFS group. Biomechanical tests may not always
be correlated with the manual examination method
and radiographies. Some reports in the literature
have stated that manual examination is the gold standard for assessing spinal fusion.[7,10,20,32] Our results
are consistent with these reports. Histopathological
results are correlated with radiographies and manual
palpation tests in the current study. The two specimens (two levels) where moderate fusion was
detected by manual palpation in the SF group
revealed a Grade C fusion on radiography and
Grades 3 and 5 on histological examination.
In conclusion, we suggest that simvastatin can
promote spinal fusion. If the bioavailability of simvastatin in the bone can be adjusted by lowering its
clearance in the liver it can be used as an adjunct to
spinal fusion procedures in elderly populations with
high cholesterol levels.
Conflicts of Interest: No conflicts declared.
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